10/07/2026
Understanding your cancer risk shouldn’t require a blood draw, a scan, or a trip to a clinic.
EG BioMed, together with YD Bio Ltd. (NASDAQ: YDES), is launching the AI Cancer Risk Assessment — a 52-question online health assessment that takes about 10 minutes to complete.
The assessment covers personal and family history, symptoms, lifestyle, environmental exposures, and diet, then generates a personalized risk report across 10 cancer types.
It combines a 48-feature pan-cancer model, 10 cancer-specific models, and a clinical literature rule layer based on more than 140 primary studies and 300+ traceable risk estimates. Each risk factor identified in your report includes an explanation and supporting reference.
Available in English and Chinese.
Promotional price: US$10
Regular price: US$50
How to get started:
Purchase the assessment online.
Your Access Code and questionnaire link will be sent to your email.
Use the Access Code to access the questionnaire and complete the assessment in about 10 minutes.
Receive your personalized risk report after completion.
Purchase here：
mdi.eg-bio.com/product/ai-cancer-risk-assessment
This assessment is for risk stratification and health guidance only. It does not diagnose cancer or replace professional medical evaluation.
